Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Gain Therapeutics (GANX) Tax Rate (2020 - 2025)

Gain Therapeutics has reported Tax Rate over the past 6 years, most recently at 0.39% for Q4 2025.

  • Quarterly results put Tax Rate at 0.39% for Q4 2025, up 1586.0% from a year ago — trailing twelve months through Dec 2025 was 27.11% (up 2981.0% YoY), and the annual figure for FY2025 was 27.11%, up 2981.0%.
  • Tax Rate for Q4 2025 was 0.39% at Gain Therapeutics, up from 11.6% in the prior quarter.
  • Over the last five years, Tax Rate for GANX hit a ceiling of 0.61% in Q4 2022 and a floor of 15.47% in Q4 2024.
  • Median Tax Rate over the past 5 years was 0.26% (2021), compared with a mean of 1.7%.
  • Biggest five-year swings in Tax Rate: tumbled -1516bps in 2024 and later skyrocketed 1586bps in 2025.
  • Gain Therapeutics' Tax Rate stood at 0.27% in 2021, then surged by 327bps to 0.61% in 2022, then plummeted by -150bps to 0.31% in 2023, then tumbled by -4923bps to 15.47% in 2024, then surged by 103bps to 0.39% in 2025.
  • The last three reported values for Tax Rate were 0.39% (Q4 2025), 11.6% (Q3 2025), and 2.49% (Q2 2025) per Business Quant data.